Together, these findings identify <i>MAGED2</i> as a conserved marker of liver cancer in both humans and mice and emphasize the importance of cross-species comparative approaches for selecting appropriate models and accurately interpreting results, particularly for CTAs, which often evolved recently and in a species-specific manner. This evidence concerns the gene MAGED2 and liver cancer.